Allogeneic stem cell transplantation (allo HCT) is a curative treatment for follicular
lymphoma, but is hampered by a relatively high treatment-related mortality and by difficulties …

Follicular non-Hodgkin's lymphomas usually present in advanced stage and although
frequently are chemotherapy-sensitive remain incurable using conventional approaches …

Myeloablative allogeneic transplantation in follicular lymphoma has been found to be
particularly effective in patients with relapsed disease and an inadequate bone marrow …

Introduction: High-dose chemotherapy and autologous stem cell transplantation (ASCT)
improve survival in follicular lymphoma; however, relapse remains the most common cause …

Follicular non-Hodgkin's lymphomas (NHL) usually present in advanced stage and although
frequently are chemotherapy-sensitive remain incurable using conventional approaches …

Follicular lymphoma (FL) exhibits striking biologic and clinical heterogeneity. Patients with
newly diagnosed asymptomatic or low-bulk disease may be observed or managed with …

Treatment options for follicular lymphoma have expanded dramatically. The most important
relate to the introduction of monoclonal antibodies and the completion of important studies …

Allogeneic stem cell transplantation (Allo-SCT) remains an option for patients with follicular
lymphoma (FL). We performed a retrospective analysis to examine long-term disease control …

The overall survival with follicular lymphoma has not significantly changed over the last few
decades, and there is no universal agreement as to the optimal first-line or subsequent …

The data on myeloablative therapy followed by autologous stem cell transplantation or
allogeneic transplantation are encouraging. Allogeneic transplantation with dose-reduced …